In addition, METTL3 deficiency enhanced the sensitivity of HB cells to ferroptosis, suggesting that blockade of the m6A‐SLC7A11 axis might represent a potential therapeutic approach against HB. This evidence concerns the gene METTL3 and hemoglobin measurement.